Anstee, Quentin M.; Darlay, Rebecca; Cockell, Simon et al.
"Genome-wide association study of non- alcoholic fatty liver and steatohepatitis in a histologically characterised cohort"( vol 73, pp 505-515 , 2020 )JOURNAL OF HEPATOLOGY. Bd. 78. H. 5. 2023 S. 1085-1086
Lazarus, Jeffrey V.; Mark, Henry E.; Allen, Alina M. et al.
A global action agenda for turning the tide on fatty liver diseaseHEPATOLOGY. 2023
Scherrer, Alexander; Zimmermann, Tobias; Riedel, Sinan et al.
A hybrid artificial intelligence solution approach to aftercare for cancer patientsNEURAL COMPUTING & APPLICATIONS. Bd. 35. H. 29. 2023 S. 21381-21397
Wolf, Jan; Alt, Siegmund; Kramer, Irene et al.
A Novel Monoclonal Antibody Degrades the Thyrotropin Receptor Autoantibodies in Graves' DiseaseENDOCRINE PRACTICE. Bd. 29. H. 7. 2023 S. 553-559
Falter, Tanja; Rossmann, Heidi; de Waele, Laure et al.
A novel von Willebrand factor multimer ratio as marker of disease activity in thrombotic thrombocytopenic purpuraBLOOD ADVANCES. Bd. 7. H. 17. 2023 S. 5091-5102
Perez-Diaz-del-Campo, Nuria; Dileo, Eleonora; Castelnuovo, Gabriele et al.
A nutrigenetic precision approach for the management of non-alcoholic fatty liver diseaseCLINICAL NUTRITION. Bd. 42. H. 11. 2023 S. 2181-2187
Janjigian, Yelena Y.; Shitara, Kohei; Moehler, Markus et al.
A plain language summary of the CheckMate 649 study: nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagusFUTURE ONCOLOGY. Bd. 19. H. 11. 2023 S. 739-752
Pais, Raluca; Cariou, Bertrand; Noureddin, Mazen et al.
A proposal from the liver forum for the management of comorbidities in non-alcoholic steatohepatitis therapeutic trialsJOURNAL OF HEPATOLOGY. Bd. 79. H. 3. 2023 S. 829-841
Govaere, Olivier; Hasoon, Megan; Alexander, Leigh et al.
A proteo-transcriptomic map of non-alcoholic fatty liver disease signaturesNATURE METABOLISM. Bd. 5. H. 4. 2023 S. 572-+
Newsome, Philip N.; Sanyal, Arun J.; Neff, Guy et al.
A randomised Phase IIa trial of amine oxidase copper-containing 3 (AOC3) inhibitor BI 1467335 in adults with non-alcoholic steatohepatitisNATURE COMMUNICATIONS. Bd. 14. H. 1. 2023